LIMN Liminatus Pharma, Inc.

Nasdaq liminatuspharma.com


$ 0.71 $ -0.15 (-17.14 %)    

Friday, 21-Nov-2025 14:02:01 EST
QQQ $ 595.18 $ 7.85 (1.34 %)
DIA $ 465.04 $ 5.57 (1.21 %)
SPY $ 663.25 $ 8.24 (1.26 %)
TLT $ 89.33 $ -0.33 (-0.36 %)
GLD $ 375.79 $ 1.80 (0.48 %)
$ 1.05
$ 0.82
$ 0.71 x 100
$ 0.73 x 100
$ 0.63 - $ 0.82
$ 1.02 - $ 33.66
124,561
na
28.36M
$ -1.11
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 11-14-2025 09-30-2025 10-Q
2 10-04-2025 06-30-2025 10-Q
3 05-31-2025 03-31-2025 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), La Palma, CA, a clinical-stage immuno-oncology company developing next-generation CD47-bl...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

Core News & Articles

Liminatus Pharma, Inc. (NASDAQ:LIMN), a preclinical-stage biopharmaceutical company dedicated to the development of targeted ca...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION